Diverse group of men and women at a conference

Biostatistics & Research
Decision Sciences
(BARDS)

Using quantitative science to impact human health

BARDS (Biostatistics and Research Decision Sciences) is a highly distinguished department within MSD’s renowned research and development division.  As esteemed members of world-class drug and vaccine development teams, we partner with other disciplines in the strategic design of our discovery and development programs and provide statistical analysis, reporting and data interpretation to enable informed decision-making. Our aspiration is to be the leader in quantitative scientific methodology and its application to enable the targeting, discovery, development, manufacturing, and marketing of innovative products for the benefit of global human health. 
Yes, we’re scientists. But we’re also communicators, problem solvers and discoverers. Our team shares different perspectives to help make our ideas a reality
and discover new ways to save and improve lives. It’s all about working together to make a difference. Find out how.

Meet the talent

Could you turn high-quality statistical data into crucial insights and knowledge for our company? It's a hugely exciting area of growth, harnessing big data's power to create life-changing medical trials and products. Meet Harris, whose analytical talents have earned him the role of Director of Statistical Programming in our BARDS unit within the Quantitative Science team. He's also a talented basketball player and has been playing it passionately since he was six. If you like what you're hearing, browse our open job roles at the bottom of the page.

Areas of collaboration and expertise for statisticians and statistical programmers

700
Employees in biostatistics and statistical programming
13
American Statistical Association Fellows
3 Regions across the globe
1 Highly rewarding, highly impactful career
80+
Years of excellence


MSD was the first company in the pharmaceutical industry to have a dedicated statistics department
12
Areas of collaboration and expertise:
  • Drug discovery
  • Translational medicine and biomarkers
  • Clinical pharmacology
  • Clinical development (products in oncology, vaccines, neuroscience, diabetes, cardiovascular health, infectious diseases, respiratory health, and immunology)
  • Safety monitoring
  • Health technology assessment
  • Manufacturing
  • Analysis and reporting standards
  • Data standards
  • Information technology
  • Health economics
  • Epidemiology



How can “I” contribute to MSD?

img1
Invent
  • Conduct research on statistical methodology
  • Apply statistical excellence daily in the development of innovative medicines and vaccines
  • Develop cutting-edge programming solutions to​​​​​​​ expedite analysis work and speed patient access to new medicines
img1
Impact
  • Directly contribute to the development of life-saving and health preserving medicines and vaccines
  • Demonstrate leadership within your field and on cross-disciplinary teams
img1
Inspire
  • Let our rich history, world-class scientists and future plans inspire you
  • Inspire others with your energy, creativity, teamwork and dedication
img1
Interact
  • With top scientists, regulators, and payers worldwide
img1
Investigate
  • The roles of precision medicine, real-world evidence, machine learning and programming automation in drug development
img1
Integrate
  • Statistical expertise with scientific advances, operational excellence and exceptional medical knowledge
Everyone in our Biostatistics and Research Decision Sciences team is passionate about wanting to improve global human health, and that passion is on display every day through our teamwork and innovation.
static img alt text
Devan Mehrotra
VP Early Development Statistics, BARDS
This field of clinical statistical assessment in Health Technology Assessment (HTA) is rapidly growing and expanding in methodological complexity and geographic scale, so it’s exciting to be at the technical and managerial forefront of an area that is all about trying to improve public health.
Lara Wolfson
Executive Director Health Technology Assessment (HTA) Statistics, BARDS
With our strong focus on methodological research, our Biostatistics and Research Decision Sciences team will continue to play a crucial role in our Research Labs decision making far into the future.
Ray Bain
SVP, BARDS
Media player
Media player
Media player
Media player

Lorem Ipsum

Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.

Lorem Ipsum

Connect with us on social

Beware of hiring scams. Review our Applicant Notice.

This careers website is intended for Residents of Europe, Middle East, Africa, Latin America & Asia Pacific. Residents in the United States, Canada & Puerto Rico, please visit this Careers website. Information on this site is for the purpose of presenting career opportunities at our organisation and give our audience a view of our culture, diversity and growth opportunities. Our Company is an equal opportunity employer, proudly embracing diversity in all of its manifestations.